Comparison of Pregabalin Versus Venlafaxine XR and Placebo in the Treatment of Generalized Anxiety Disorder
Launched by PFIZER'S UPJOHN HAS MERGED WITH MYLAN TO FORM VIATRIS INC. · Sep 7, 2005
Trial Information
Current as of May 27, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Male and female outpatients with diagnosis of generalized anxiety disorder.
- Exclusion Criteria:
- • Any serious or uncontrolled medical condition.
- • Current diagnosis of depression, dysthymia, obsessive-compulsive disorder.
About Pfizer's Upjohn Has Merged With Mylan To Form Viatris Inc.
Viatris Inc. is a global healthcare company formed from the merger of Pfizer's Upjohn division and Mylan, dedicated to providing access to high-quality medicines, including generics and specialty pharmaceuticals. With a strong commitment to innovation and patient-centric solutions, Viatris leverages a diverse portfolio and extensive global reach to address the evolving healthcare needs of patients worldwide. The company aims to create sustainable healthcare solutions by combining expertise in pharmaceutical development, manufacturing, and distribution, ultimately enhancing patient outcomes and improving overall health systems.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Madrid, , Spain
Barcelona, , Spain
Barcelona, , Spain
Gent, , Belgium
Madrid, , Spain
Salamanca, , Spain
Göteborg, , Sweden
Lund, , Sweden
Stockholm, , Sweden
Linkoping, , Sweden
Hamilton, Ontario, Canada
Waregem, , Belgium
Stockholm, , Sweden
Versailles, , France
Ottawa, Ontario, Canada
Kelowna, British Columbia, Canada
De Pinte, , Belgium
Elancourt, , France
Hoogvliet, , Netherlands
Huizen, , Netherlands
Losser, , Netherlands
Ghent, , Belgium
Waregem, , Belgium
Gatineau, Quebec, Canada
Saint Jean Sur Richelieu, Quebec, Canada
Angouleme, , France
Arcachon, , France
Bully Les Mines, , France
Cherbourg, , France
Orvault, , France
Rennes, , France
Saint Andre De Cubzac, , France
Savigny Sur Orge, , France
Strasbourg, , France
Bray, County Wicklow, Ireland
Vicenza, Bassano Del Grappa, Italy
Citta' Di Castello, Perugia, Italy
Catania, , Italy
Sassari, , Italy
Wildervank, Gr, Netherlands
Musselkanaal, , Netherlands
Oude Pekela, , Netherlands
Langreo, Asturias, Spain
Vic, Barcelona, Spain
Alcala De Henares, Madrid, Spain
Gandia, Valencia, Spain
Zamora, , Spain
Malmö, , Sweden
Sundsvall, , Sweden
Trollhattan, , Sweden
Patients applied
Trial Officials
Pfizer CT.gov Call Center
Study Director
Pfizer
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials